To include your compound in the COVID-19 Resource Center, submit it here.

FDA panel to discuss Pfizer's Xeljanz for UC

FDA's Gastrointestinal Drugs Advisory Committee will meet

Read the full 76 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE